Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasculitis with alclofenac therapy.

R A Billings, H C Burry, F S Emaslie

    British Medical Journal
    |November 2, 1974
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Fenclofenac in osteoarthrosis.

    Proceedings of the Royal Society of Medicine·2010
    Same author

    Mortality in individuals with Type 2 diabetes and heart disease in a unique New Zealand population.

    Diabetic medicine : a journal of the British Diabetic Association·2006
    Same author

    Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational study.

    Alimentary pharmacology & therapeutics·2004
    Same author

    A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis.

    Alimentary pharmacology & therapeutics·2002
    Same author

    When is a change a genuine change? A clinically meaningful interpretation of grip strength measurements in healthy and disabled women.

    Journal of hand therapy : official journal of the American Society of Hand Therapists·1999
    Same author

    Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator group.

    Alimentary pharmacology & therapeutics·1999
    Same journal

    Muscular pain during therapy with carbenoxolone (Biogastrone).

    British medical journal·2016
    Same journal

    ACUTE INTESTINAL OBSTRUCTION DUE TO INTRA-ABDOMINAL CAUSES.

    British medical journal·2014
    Same journal

    A CASE OF HAEMATIDROSIS.

    British medical journal·2014
    Same journal

    Incidence of ulcer in haematemesis.

    British medical journal·2011
    Same journal

    Pituitary hypothyroidism with impaired renal function.

    British medical journal·2011
    Same journal

    The fenestration operation for otosclerosis.

    British medical journal·2011
    See all related articles

    Alclofenac use can lead to vasculitis, a serious inflammatory condition. Prompt corticosteroid treatment is crucial for recovery, as delayed intervention may worsen renal involvement.

    Area of Science:

    • Rheumatology
    • Nephrology
    • Pharmacology

    Background:

    • Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for pain and inflammation.
    • Drug-induced vasculitis is a rare but significant adverse effect.
    • Alclofenac is an NSAID with potential immunomodulatory properties.

    Purpose of the Study:

    • To report cases of vasculitis associated with alclofenac use.
    • To highlight the clinical presentation and outcomes of alclofenac-induced vasculitis.
    • To emphasize the importance of early diagnosis and management.

    Main Methods:

    • Case series describing three patients who developed vasculitis.
    • Clinical and laboratory data were reviewed.
    • Histopathological findings of renal biopsies were analyzed.

    Related Experiment Videos

    Main Results:

    • Three patients presented with systemic vasculitis while on alclofenac.
    • Two patients recovered with corticosteroid therapy.
    • One patient with persistent symptoms and delayed treatment showed progressive renal disease.

    Conclusions:

    • Alclofenac can induce vasculitis, affecting multiple organ systems.
    • Early recognition and cessation of alclofenac are vital.
    • Corticosteroid therapy is effective, but delayed treatment may lead to irreversible renal damage.